Cargando…
Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma
The interleukin (IL)‐6/glycoprotein (GP)130/signal transducer and activator of transcription (STAT)3 pathway is emerging as a target for the treatment of hepatocellular carcinoma. IL‐6 binds to IL‐6R, forming a binary complex, which further combines with GP130 to transduce extracellular signaling by...
Autores principales: | Ma, Haiyan, Yan, Dan, Wang, Yina, Shi, Wei, Liu, Tianshu, Zhao, Chongqiang, Huo, Shengqi, Duan, Jialin, Tao, Jingwen, Zhai, Maocai, Luo, Pengcheng, Guo, Junyi, Tian, Lei, Mageta, Lulu, Jou, David, Zhang, Cuntai, Li, Chenglong, Lin, Jiayuh, Lv, Jiagao, Li, Sheng, Lin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398888/ https://www.ncbi.nlm.nih.gov/pubmed/30648776 http://dx.doi.org/10.1111/cas.13940 |
Ejemplares similares
-
Bazedoxifene Attenuates Abdominal Aortic Aneurysm Formation via Downregulation of Interleukin-6/Glycoprotein 130/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Apolipoprotein E–Knockout Mice
por: Yan, Dan, et al.
Publicado: (2020) -
Inhibition of Interleukin‐6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice
por: Shi, Wei, et al.
Publicado: (2020) -
Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling
por: Wang, Yina, et al.
Publicado: (2017) -
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019) -
Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
por: Xiao, Hui, et al.
Publicado: (2017)